Bausch Health Companies Inc. Capital Expenditures
Bausch Health Companies Inc. (BHC) reported Capital Expenditures of $186.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-30
- Bausch Health Companies Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $77.00M, a 22.22% decline year-over-year.
- Bausch Health Companies Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $109.00M, a 5.22% decline year-over-year.
- Bausch Health Companies Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $92.00M, a 13.21% decline year-over-year.
- Bausch Health Companies Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $91.00M, a 28.17% increase year-over-year.
- Bausch Health Companies Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $397.00M, a 17.80% increase from fiscal 2024.
- Bausch Health Companies Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $337.00M, a 56.74% increase from fiscal 2023.
- Bausch Health Companies Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $215.00M, a 1.38% decline from fiscal 2022.
- Bausch Health Companies Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $218.00M, a 18.96% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $77.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $186.00M 10-Q · filed 2026-07-30 | $278.00M derived: sum of 3 quarters · filed 2026-07-30 | $369.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $109.00M 10-Q · filed 2026-04-30 | $201.00M derived: sum of 2 quarters · filed 2026-04-30 | $292.00M derived: sum of 3 quarters · filed 2026-04-30 | $391.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $92.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $183.00M derived: sum of 2 quarters · filed 2026-02-19 | $282.00M derived: sum of 3 quarters · filed 2026-07-30 | $397.00M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $91.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $190.00M derived: sum of 2 quarters · filed 2026-07-30 | $305.00M 10-Q · filed 2025-10-30 | $411.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $99.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $214.00M 10-Q · filed 2026-07-30 | $320.00M derived: sum of 3 quarters · filed 2026-07-30 | $391.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $115.00M 10-Q · filed 2026-04-30 | $221.00M derived: sum of 2 quarters · filed 2026-04-30 | $292.00M derived: sum of 3 quarters · filed 2026-04-30 | $370.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $106.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $177.00M derived: sum of 2 quarters · filed 2026-02-19 | $255.00M derived: sum of 3 quarters · filed 2026-02-19 | $337.00M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $71.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $149.00M derived: sum of 2 quarters · filed 2025-10-30 | $231.00M 10-Q · filed 2025-10-30 | $329.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $78.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $160.00M 10-Q · filed 2025-07-31 | $258.00M derived: sum of 3 quarters · filed 2026-02-19 | $300.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $82.00M 10-Q · filed 2025-05-01 | $180.00M derived: sum of 2 quarters · filed 2026-02-19 | $222.00M derived: sum of 3 quarters · filed 2026-02-19 | $250.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $98.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $140.00M derived: sum of 2 quarters · filed 2026-02-19 | $168.00M derived: sum of 3 quarters · filed 2026-02-19 | $215.00M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $42.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $70.00M derived: sum of 2 quarters · filed 2024-10-31 | $117.00M 10-Q · filed 2024-10-31 | $183.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $28.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $75.00M 10-Q · filed 2024-08-01 | $141.00M derived: sum of 3 quarters · filed 2025-02-20 | $195.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $47.00M 10-Q · filed 2024-05-02 | $113.00M derived: sum of 2 quarters · filed 2025-02-20 | $167.00M derived: sum of 3 quarters · filed 2025-02-20 | $219.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $66.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $120.00M derived: sum of 2 quarters · filed 2025-02-20 | $172.00M derived: sum of 3 quarters · filed 2025-02-20 | $218.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $54.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $106.00M derived: sum of 2 quarters · filed 2023-11-02 | $152.00M 10-Q · filed 2023-11-02 | $230.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $52.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $98.00M 10-Q · filed 2023-08-03 | $176.00M derived: sum of 3 quarters · filed 2024-02-22 | $239.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $46.00M 10-Q · filed 2023-05-04 | $124.00M derived: sum of 2 quarters · filed 2024-02-22 | $187.00M derived: sum of 3 quarters · filed 2024-02-22 | $249.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $78.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $141.00M derived: sum of 2 quarters · filed 2024-02-22 | $203.00M derived: sum of 3 quarters · filed 2024-02-22 | $269.00M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $63.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $125.00M derived: sum of 2 quarters · filed 2022-11-03 | $191.00M 10-Q · filed 2022-11-03 | $271.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $62.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $128.00M 10-Q · filed 2022-08-09 | $208.00M derived: sum of 3 quarters · filed 2023-02-23 | $289.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $66.00M 10-Q · filed 2022-05-10 | $146.00M derived: sum of 2 quarters · filed 2023-02-23 | $227.00M derived: sum of 3 quarters · filed 2023-02-23 | $296.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $80.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $161.00M derived: sum of 2 quarters · filed 2023-02-23 | $230.00M derived: sum of 3 quarters · filed 2023-02-23 | $302.00M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $81.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $150.00M derived: sum of 2 quarters · filed 2021-11-02 | $222.00M 10-Q · filed 2021-11-02 | $300.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | $69.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $141.00M 10-Q · filed 2021-08-03 | $219.00M derived: sum of 3 quarters · filed 2022-05-11 | $302.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | $72.00M 10-Q · filed 2021-05-04 | $150.00M derived: sum of 2 quarters · filed 2022-05-11 | $233.00M derived: sum of 3 quarters · filed 2022-05-11 | $295.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | $78.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $161.00M derived: sum of 2 quarters · filed 2022-05-11 | $223.00M derived: sum of 3 quarters · filed 2022-05-11 | $270.00M 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | $83.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $145.00M derived: sum of 2 quarters · filed 2020-11-03 | $192.00M 10-Q · filed 2020-11-03 | $254.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | $62.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $109.00M 10-Q · filed 2020-08-06 | $171.00M derived: sum of 3 quarters · filed 2021-05-04 | $203.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $47.00M 10-Q · filed 2020-05-07 | $109.00M derived: sum of 2 quarters · filed 2021-05-04 | $141.00M derived: sum of 3 quarters · filed 2021-05-04 | $171.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $62.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $94.00M derived: sum of 2 quarters · filed 2021-05-04 | $124.00M derived: sum of 3 quarters · filed 2021-05-04 | $157.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $32.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $62.00M derived: sum of 2 quarters · filed 2019-11-04 | $95.00M 10-Q · filed 2019-11-04 | $148.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $30.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $63.00M 10-Q · filed 2019-08-06 | $116.00M derived: sum of 3 quarters · filed 2020-02-19 | $159.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $33.00M 10-Q · filed 2019-05-06 | $86.00M derived: sum of 2 quarters · filed 2020-02-19 | $129.00M derived: sum of 3 quarters · filed 2020-02-19 | $166.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $96.00M derived: sum of 2 quarters · filed 2020-02-19 | $133.00M derived: sum of 3 quarters · filed 2020-02-19 | $171.00M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $43.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $80.00M derived: sum of 2 quarters · filed 2018-11-06 | $118.00M 10-Q · filed 2018-11-06 | $172.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $37.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $75.00M 10-Q · filed 2018-08-07 | $129.00M derived: sum of 3 quarters · filed 2019-02-20 | $182.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $38.00M 10-Q · filed 2018-05-08 | $92.00M derived: sum of 2 quarters · filed 2019-02-20 | $145.00M derived: sum of 3 quarters · filed 2019-02-20 | $211.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $54.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $107.00M derived: sum of 2 quarters · filed 2019-02-20 | $173.00M derived: sum of 3 quarters · filed 2019-02-20 | $235.00M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | $53.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $119.00M derived: sum of 2 quarters · filed 2017-11-07 | $181.00M 10-Q · filed 2017-11-07 | $181.10M 10-Q · filed 2016-11-09 | $252.30M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | $66.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $128.00M 10-Q · filed 2017-08-08 | $128.30M 10-Q · filed 2016-08-09 | $199.30M derived: sum of 3 quarters · filed 2018-08-10 | $250.40M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | $62.00M 10-Q · filed 2017-05-09 | $62.30M 10-Q · filed 2016-06-07 | $133.30M derived: sum of 2 quarters · filed 2018-08-10 | $184.40M derived: sum of 3 quarters · filed 2018-08-10 | $231.20M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $71.30M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $122.40M derived: sum of 2 quarters · filed 2018-08-10 | $169.20M derived: sum of 3 quarters · filed 2018-08-10 | $235.00M 8-K · filed 2018-08-10 | $235.20M 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $51.10M 10-Q · filed 2015-10-26 | $97.90M derived: sum of 2 quarters · filed 2015-10-26 | $163.70M 10-Q · filed 2016-11-09 | $244.50M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $46.80M 10-Q · filed 2015-07-28 | $112.60M 10-Q · filed 2016-08-09 | $193.40M derived: sum of 3 quarters · filed 2017-03-01 | $233.00M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $65.80M 10-Q · filed 2016-06-07 | $146.60M derived: sum of 2 quarters · filed 2017-03-01 | $186.20M derived: sum of 3 quarters · filed 2017-03-01 | $299.70M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $80.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $120.40M derived: sum of 2 quarters · filed 2017-03-01 | $233.90M derived: sum of 3 quarters · filed 2017-03-01 | $292.00M 10-K · filed 2017-03-01 | $291.60M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $39.60M 10-Q · filed 2015-10-26 | $153.10M derived: sum of 2 quarters · filed 2015-10-26 | $211.20M 10-Q · filed 2015-10-26 | $274.80M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $113.50M 10-Q · filed 2015-07-28 | $171.60M 10-Q · filed 2015-07-28 | $235.20M derived: sum of 3 quarters · filed 2016-04-29 | $260.10M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $58.10M 10-Q · filed 2015-04-30 | $121.70M derived: sum of 2 quarters · filed 2016-04-29 | $146.60M derived: sum of 3 quarters · filed 2016-04-29 | $159.40M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $63.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $88.50M derived: sum of 2 quarters · filed 2016-04-29 | $101.30M derived: sum of 3 quarters · filed 2016-04-29 | $115.30M 10-K · filed 2016-04-29 | $115.32M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $24.90M 10-Q · filed 2014-10-24 | $24.93M 10-Q · filed 2013-11-01 | $37.70M derived: sum of 2 quarters · filed 2014-10-24 | $51.70M 10-Q · filed 2014-10-24 | $51.73M 10-Q · filed 2013-11-01 | $77.51M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $12.80M 10-Q · filed 2014-08-01 | $12.76M 10-Q · filed 2013-08-07 | $26.80M 10-Q · filed 2014-08-01 | $26.80M 10-Q · filed 2013-08-07 | $52.61M derived: sum of 3 quarters · filed 2015-02-25 | $109.68M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $14.00M 10-Q · filed 2014-05-09 | $14.04M 10-Q · filed 2013-05-03 | $39.81M derived: sum of 2 quarters · filed 2015-02-25 | $96.88M derived: sum of 3 quarters · filed 2015-02-25 | $110.48M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $25.81M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $82.88M derived: sum of 2 quarters · filed 2015-02-25 | $96.48M derived: sum of 3 quarters · filed 2015-02-25 | $107.60M 10-K · filed 2015-02-25 | $107.64M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $57.07M 10-Q · filed 2013-11-01 | $70.67M derived: sum of 2 quarters · filed 2013-11-01 | $81.79M 10-Q · filed 2013-11-01 | $96.74M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $13.60M 10-Q · filed 2013-08-07 | $24.72M 10-Q · filed 2013-08-07 | $39.67M derived: sum of 3 quarters · filed 2014-02-28 | $49.25M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $11.12M 10-Q · filed 2013-05-03 | $26.07M derived: sum of 2 quarters · filed 2014-02-28 | $35.65M derived: sum of 3 quarters · filed 2014-02-28 | $48.13M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $14.95M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $24.54M derived: sum of 2 quarters · filed 2014-02-28 | $37.01M derived: sum of 3 quarters · filed 2014-02-28 | $58.52M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $9.58M 10-Q · filed 2012-11-05 | $22.06M derived: sum of 2 quarters · filed 2012-11-05 | $43.56M 10-Q · filed 2012-11-05 | $52.85M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $12.47M 10-Q · filed 2012-08-03 | $33.98M 10-Q · filed 2012-08-03 | $43.27M derived: sum of 3 quarters · filed 2013-02-28 | $44.31M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $21.50M 10-Q · filed 2012-05-04 | $30.80M derived: sum of 2 quarters · filed 2013-02-28 | $31.83M derived: sum of 3 quarters · filed 2013-02-28 | $34.69M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $9.29M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $10.33M derived: sum of 2 quarters · filed 2013-02-28 | $13.19M derived: sum of 3 quarters · filed 2013-02-28 | $16.82M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $1.04M 10-Q · filed 2011-11-04 | $3.90M derived: sum of 2 quarters · filed 2011-11-04 | $7.53M 10-Q · filed 2011-11-04 | $12.24M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | $2.86M 10-Q · filed 2011-08-08 | $6.49M 10-Q · filed 2011-08-08 | $11.21M derived: sum of 3 quarters · filed 2012-02-29 | $12.29M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | $3.63M 10-Q · filed 2011-05-10 | $8.35M derived: sum of 2 quarters · filed 2012-02-29 | $9.43M derived: sum of 3 quarters · filed 2012-02-29 | $10.27M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $5.79M derived: sum of 2 quarters · filed 2012-02-29 | $6.64M derived: sum of 3 quarters · filed 2012-02-29 | $7.42M 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $1.08M 10-Q · filed 2010-11-05 | $1.93M derived: sum of 2 quarters · filed 2010-11-05 | $2.71M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $842.00K 10-Q · filed 2010-08-06 | $1.63M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | $22.00M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |